FIELD: medicine, pharmacy. SUBSTANCE: invention relates to curative-prophylactic agents normalizing functions of genital organs, arresting amenorrhea, development of neurological and osteoporosis symptoms in preclimacteric or climacteric periods. The proposed agent comprises glutamic acid or its pharmaceutically acceptable salts, glycine, calcium acid succinate, magnesium acid succinate, zinc acid fumarate, tocopherol acetate and ammonium succinate. Invention provides effect of agents normalizing functional disorders in menstrual cycle and estrogen background. Agent provides arresting in development of neurological and osteoporous pathological disorders, sleep disorder, depression in preclimacteric and climacteric period, to treat pathological amenorrhea, to prevent neurological symptoms of premenstrual syndrome, enhances energetic status of body. Agent shows antioxidant and adaptogenic properties also, it reduces weather dependence, normalizes endocrine system state, elicits hypoglycemic effect and reduces intensity of climacteric bleedings. EFFECT: enhanced and valuable medicinal properties of agent. 10 cl
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATING HOT FLASHES AND RECUPERATING MENSTRUAL CYCLE DURING PERIMENOPAUSE AND METHOD OF USING IT | 2019 |
|
RU2736997C1 |
AGENT ELICITING HEPATOPROTECTIVE PROPERTY, FOR REDUCING ALCOHOLIC INTOXICATION, PROPHYLAXIS AND ELIMINATION OF ALCOHOLIC INTOXICATION AND ALCOHOL WITHDRAWAL SYNDROME | 2003 |
|
RU2240789C1 |
PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF MENOPAUSE OSTEOPOROSIS IN WOMEN | 2007 |
|
RU2379043C2 |
PHARMACEUTICAL PREPARATION FOR EXTERNAL AND LOCAL APPLICATION, BASED ON SYGETHIN | 2007 |
|
RU2363461C2 |
LOCAL AND EXTERNAL SYGETHIN-BASED PHARMACEUTICAL COMPOSITION FOR MENOPAUSAL DISORDERS PREVENTION AND TREATMENT | 2007 |
|
RU2356548C1 |
SYGETHIN-BASED PHARMACEUTICAL STRUCTURE FOR OSTEOPOROSIS PREVENTION AND TREATMENT (VERSIONS) | 2007 |
|
RU2356546C1 |
AGENT FOR REDUCING ALCOHOLIC DRUNKENNESS, PREVENTING AND ELIMINATING ALCOHOL INTOXICATION AND HANGOVER SYNDROME AND METHOD FOR REDUCING ALCOHOLIC DRUNKENNESS, PREVENTING AND ELIMINATING ALCOHOL INTOXICATION AND HANGOVER SYNDROME USING THIS AGENT | 2000 |
|
RU2160589C1 |
ANTI-OSTEOPOROSIS AGENT | 2015 |
|
RU2582973C1 |
AGENT FOR CORRECTING MENSTRUAL IRREGULARITIES, MENOPAUSAL DISORDERS | 2022 |
|
RU2801514C1 |
COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING MENOPAUSAL SYNDROME IN FEMALES, CONTAINING LOGANIN OR DERIVATIVES THEREOF AS AN ACTIVE INGREDIENT | 2017 |
|
RU2697672C1 |
Authors
Dates
2004-01-10—Published
2002-07-18—Filed